Board Meeting
Medico Intercontinental Board Meeting Scheduled
Medico Intercontinental will hold a Board meeting on 6 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
7
Bullish
2
Bearish
26
Neutral
7
Bullish
13
Bearish
21
Neutral
0
Bullish
11
Upcoming Result Date: Nov 05, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Medico Intercontinental Ltd (MIL) is currently trading at 24.69 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Medico Intercontinental Limited specializes in the trading of pharmaceutical products. The company acts as a platform for bio-pharmaceutical companies, facilitating global access to novel therapies. Medico's focus includes using advanced scientific technology aimed at discovering new treatments for rare diseases. The company is deeply committed to improving patient outcomes, prioritizing patient needs in their innovative medical pursuits.,
Over the past 52 weeks, Medico Intercontinental Ltd has traded between a low of ₹20.61 and a high of ₹43.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Medico Intercontinental Ltd has a market capitalization of approximately 24.69. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Medico Intercontinental Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -1.96 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 24.69 Cr, Medico Intercontinental Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Medico Intercontinental Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Medico Intercontinental Ltd is -1.96. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Commercial Services & Supplies
Trading & Distributors
25 Cr
Low Risk
-2.0
19.8
—
0.5
43.00
20.61
Sales CAGR
Profit CAGR
ROE
ROCE
